Numeta G19e (Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio)

Numeta G19e is used in clinical nutrition to support patients who cannot receive oral intake. It is indicated for:

• Post‑operative recovery: helps maintain protein synthesis and nitrogen balance.
• Critical illness: provides essential amino acids for metabolic support.
• Long‑term parenteral nutrition: sustains nutritional needs when enteral feeding is not possible.
• Pre‑transplant conditioning: assists in maintaining nutritional status before transplantation.
• Severe malnutrition: aids in restoring amino acid deficits.

• Numeta G19e delivers a balanced mixture of essential and conditionally essential amino acids directly into the bloodstream. The amino acids serve as substrates for protein synthesis, support nitrogen balance, and act as precursors for neurotransmitters and metabolic intermediates, thereby helping to maintain cellular function during periods of limited oral intake.

Numeta G19e may be associated with infusion‑related reactions and metabolic disturbances.

Common Side Effects

• Mild fever: transient elevation of body temperature during infusion.
• Local irritation: redness or discomfort at the infusion site.
• Nausea: occasional feeling of queasiness.
• Headache: mild to moderate headache during or after infusion.
• Electrolyte shift: minor changes in serum electrolytes.
• Hyperglycemia: temporary rise in blood glucose levels.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate medical attention.
• Sepsis: infection related to catheter use.
• Metabolic acidosis: significant acid‑base imbalance.
• Hyperammonemia: elevated ammonia levels in blood.
• Thrombophlebitis: inflammation of the vein with clot formation.
• Renal impairment: worsening kidney function in susceptible patients.

When using Numeta G19e, clinicians should consider several safety measures.

• Monitor electrolytes: regular blood tests to detect imbalances.
• Assess renal function: check kidney parameters before and during therapy.
• Observe for infection: watch catheter sites for signs of infection.
• Adjust glucose: manage blood sugar in diabetic patients.
• Evaluate liver status: liver function tests are recommended.
• Store at ambient temperature: keep in original packaging, protect from light and moisture.

Numeta G19e may interact with other intravenous solutions and medications.

Major Interactions (Avoid)

• High‑dose potassium chloride: can cause dangerous electrolyte overload.
• Acidic drug solutions: may precipitate amino acids, reducing efficacy.

Moderate Interactions (Monitor Closely)

• Diuretics: may amplify electrolyte shifts.
• Insulin therapy: increased risk of hypoglycemia when combined with glucose‑containing solutions.
• Anticoagulants: potential alteration of coagulation parameters.
• Other parenteral nutrition formulations: risk of nutrient excess.
• Vasopressors: may affect peripheral circulation at infusion sites.